glp 1 drugs and vision loss ๐ Optometrists are warning GLP-1 may pose these types of rare risks ๐ โฌ๏ธ Details in comments GLP-1 Drugs Like Ozempic Face
Description
25 Significantly, only a meta-analysis demonstrated the risk reduction in HF hospitalisation

The FDA has approved the following GLP-1 medications for heart health

Concerns regarding pancreatitis have not been substantiated in large cardiovascular outcome trials (92, 93)

Those on Mounjaro lost an average of 11.9 lbs (5.4 kgs) with a 5 mg dose, 16.5 lbs (7.5 kgs) with a 10 mg dose, and 19.4 lbs (8.8 kgs) with a 15 mg dose
Direct head-to-head comparisons are not possible because the trials differed in duration, population and study design, but reporting outcomes side-by-side provides context
